Back to MA Mirae Asset Global Investments Co., Ltd.

TXGTXG

Showing 8 of 15 quarters

Position history for MAMirae Asset Global Investments Co., Ltd.'s holdings in 10x Genomics, Inc.

Yes. Mirae Asset Global Investments holds 49,696 shares of TXG (10x Genomics), worth $4.5M, as of its Q3 2026 13F filing. It increased the position from 5,227 shares in Q2 2026. Mirae Asset Global Investments has held TXG since Q4 2024, across 8 quarterly 13F filings.

Current Value

$4.5M

Current Shares

49,696

Total Value Change

+$4.4M

Total Shares Change

+46,130

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
49,696
+850.8%
$4.5M0.0%$90.36
43
2026-Q2
Decreased
5,227
-14.8%
$200,4030.0%$38.34
0
2026-Q1
Increased
6,138
+8.4%
$130,3100.0%$21.23
24
2025-Q4
Increased
5,660
+28.0%
$92,3150.0%$16.31
27
2025-Q3
Increased
4,423
+3.1%
$51,7050.0%$11.69
21
2025-Q2
Increased
4,291
+18.5%
$49,6900.0%$11.58
24
2025-Q1
Increased
3,622
+1.6%
$33,1780.0%$8.73
20
2024-Q4
New
3,566
—
$52,0280.0%$14.36
28

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used